← Latest papers
📄 medicine

Seasonal malaria chemoprevention uptake among caregivers of children under five in Abuja, Nigeria: a mixed-methods study of awareness, determinants, barriers and facilitators

This mixed-methods study in Abuja, Nigeria, reveals that while awareness of Seasonal Malaria Chemoprevention (SMC) is high among caregivers of children under five, actual uptake remains suboptimal due to barriers such as inconsistent drug availability and inconvenient distribution, highlighting the need for improved sensitization, supply reliability, and flexible delivery strategies to enhance participation.

Original authors: Nana Aisha El-yakub, Saddiq Abdurrahman, Luke Oche Peter

Published 2026-08-12
📖 5 min read🧠 Deep dive

Original authors: Nana Aisha El-yakub, Saddiq Abdurrahman, Luke Oche Peter

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

The Invisible Shield and the Busy Parent

Imagine a invisible shield that protects young children from a sneaky, mosquito-borne villain called malaria. This shield isn't made of metal or magic; it's a special medicine called Seasonal Malaria Chemoprevention, or SMC for short. Think of it like a "malaria raincoat" that doctors and community workers give to kids under five years old during the rainy season when mosquitoes are most active. The goal is simple: give the kids the medicine before they get sick, so they stay healthy and don't have to visit the hospital.

But here's the tricky part: having the shield is one thing; actually putting it on is another. Even if everyone knows the shield exists, getting every single parent to use it can be hard. Maybe they are too busy at work, maybe they are worried about side effects, or maybe they just didn't hear when the shield was being handed out. Scientists care deeply about this because if we can figure out exactly why some parents say "yes" and others say "no," we can fix the system and save more lives. This isn't just about medicine; it's about understanding how real people live, work, and make decisions.


The Abuja Detective Story: Why Some Shields Get Used and Others Don't

In the bustling city of Abuja, Nigeria, a team of researchers decided to play detective. They wanted to solve a mystery: Why do some parents of young children use the SMC "malaria raincoat," while others don't? They didn't just guess; they interviewed 317 parents and held group chats with 27 more to get the full picture.

The Big Reveal: Knowing is the First Step
The first thing the detectives found was that most people knew about the shield. About 81.7% of the parents had heard of SMC. But here's the twist: just knowing about it didn't mean they used it. Only 60.6% of the parents actually gave the medicine to their kids.

The study found that the single biggest reason a parent used the medicine was simply that they knew it existed. If a parent had heard of the program, they were nearly 18 times more likely to use it than someone who hadn't heard of it. It's like knowing a secret treasure map exists; if you don't know the map is there, you'll never find the treasure.

The Busy Parent Paradox
Here is where the story gets a little ironic. The researchers found that parents who were employed (working a job) were actually less likely to use the medicine than those who weren't working. Wait, didn't we say working parents were more likely to use it in the raw numbers? Yes, but when the scientists looked closer, they realized that working parents were just too busy to be home when the medicine distributors arrived.

Imagine a delivery driver showing up at your house at 7:00 AM to drop off a package, but you are already at work. You miss the package! The study showed that employed caregivers had 0.24 times the odds of using the medicine compared to unemployed ones. It wasn't that they didn't want the medicine; it was that the timing didn't fit their busy lives.

The Safety Net of Insurance
On the flip side, parents who had health insurance were almost twice as likely (1.95 times) to use the medicine. It seems that having a safety net for health costs made parents feel more confident and ready to participate in prevention programs.

The "Why" Behind the Numbers
The researchers didn't just stop at the numbers; they listened to the parents' stories to understand the "why."

  • The Good Stuff: Parents loved the idea of the medicine being brought right to their doorstep. It saved them money on bus fare and time. They also trusted the medicine because they saw it work—fewer sick days for their kids meant fewer trips to the hospital.
  • The Bad Stuff: The biggest hurdles were fear of side effects (like fever or weakness) and missing the delivery. Sometimes the medicine wasn't there when the workers came, or the workers came when the parents were at work. Some parents also heard scary rumors, like the medicine affecting fertility, which made them hesitate.

The Verdict
The study concludes that while we have done a great job telling people about the "malaria raincoat," we need to do better at making sure they can actually put it on. The researchers suggest that if we fix the timing so working parents can be home, if we make sure the medicine is always in stock, and if we explain clearly what side effects might happen so parents don't panic, more families will use the shield.

The paper doesn't claim to have solved malaria, but it does suggest that by listening to parents and fixing these small, practical problems, we can make the "malaria raincoat" work for everyone, not just the lucky few.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →